Lonza
Patric Somlo is a professional with extensive experience in finance and strategy. Currently serving as a Board Member at BioAtrium AG and Ergolz-Klinik, Patric has held various leadership positions including Head of Financial Planning & Analysis at Lonza and Director of Private Equity at Jacobs Holding. With a background in computer science and a Master's degree from ETH Zurich, Patric's expertise spans across industries such as technology, private equity, and biologics. Additionally, Patric holds an MBA from Columbia Business School and is a certified expert for IFRS accounting.
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.